Previous Page  3 / 12 Next Page
Information
Show Menu
Previous Page 3 / 12 Next Page
Page Background

Page 20

Notes:

conferenceseries

.com

Volume 4, Issue 4 (Suppl)

J Pharma Care Health Sys

ISSN: 2376-0419, JPCHS, an open access journal

Pharma Middle East 2017

September 25-26, 2017

September 25-26, 2017 Dubai, UAE

12

th

Annual Pharma Middle East Congress

Development of gastro-retentive drug delivery systems based on N-isopropyl acrylamide hydrogels

Rubab Zohra

Forman Christian College, Pakistan

I

t was planned to synthesize dual-responsive hydrogels from N-isopropyl acrylamide (NiPAAm), acrylic acid (AA) and

methacrylate (MA). Hydrogels were prepared by free radical copolymerization using ethyl alcohol as a solvent, a redox

initiator, benzoyl peroxide (BPO) and ethylene glycol dimethacrylate (EGDMA) and diethylene glycol dimethacrylate

(DEGDMA) as cross-linkers. The network parameters like polymer mesh size (ξ) (23.78 to 820 Å), molecular weight between

the cross-links (M

c

) (970-356096 gmol-1) and crosslink density (q), (0.0928 to 0.00025) were calculated at various pH using the

Flory-Rehner theory. Hydrogels exhibited the non-Fickian diffusion mechanism. FTIR spectral analysis and (TGA/DSC) were

carried out to characterize the systems and new LCST was found to be increased. Tramadol HCl was used as the model drug to

investigate the drug loading and unloading behavior of these gels. It was concluded that these systems exhibited a sharp change

in their media sorption capacity and mesh size of the networks with the change in the pH and temperature of the swelling

media, proposing their strong candidature for being used as oral drug delivery systems. The results favored the idea to apply

these hydrogels to use as targeted drug delivery systems for the proximal part of the gastro-intestinal tract.

Biography

Rubab Zohra is working as an Associate Professor at Department of Chemistry in Forman Christian College (A Chartered University), Lahore, Pakistan.

rubabzohra@gmail.com

Rubab Zohra, J Pharma Care Health Sys 2017, 4:4 (Suppl)

DOI: 10.4172/2376-0419-C1-023